Cardinal Capital Management Inc (North Carolina)’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-31,208
Closed -$549K 133
2019
Q1
$549K Buy
31,208
+1,136
+4% +$18.9K 0.16% 116
2018
Q4
$522K Buy
30,072
+1,160
+4% +$19.8K 0.17% 112
2018
Q3
$430K Sell
28,912
-40
-0.1% -$620 0.12% 123
2018
Q2
$460K Buy
28,952
+543
+2% +$8.1K 0.14% 121
2018
Q1
$403K Buy
28,409
+85
+0.3% +$1.26K 0.13% 113
2017
Q4
$397K Sell
28,324
-1,335
-5% -$19.5K 0.12% 114
2017
Q3
$424K Sell
29,659
-26,258
-47% -$375K 0.13% 115
2017
Q2
$881K Buy
55,917
+10,108
+22% +$146K 0.29% 89
2017
Q1
$632K Buy
45,809
+5,846
+15% +$81.7K 0.23% 94
2016
Q4
$707K Buy
39,963
+2,074
+5% +$36.4K 0.27% 90
2016
Q3
$731K Buy
37,889
+3,671
+11% +$71.8K 0.29% 82
2016
Q2
$667K Buy
34,218
+2,081
+6% +$40.8K 0.27% 84
2016
Q1
$662K Buy
32,137
+2,512
+8% +$49.5K 0.28% 79
2015
Q4
$608K Buy
29,625
+1,268
+4% +$24.3K 0.27% 81
2015
Q3
$485K Buy
28,357
+4,056
+17% +$74.1K 0.23% 90
2015
Q2
$453K Buy
24,301
+5,444
+29% +$101K 0.2% 91
2015
Q1
$360K Buy
18,857
+4,416
+31% +$81.7K 0.15% 96
2014
Q4
$238K Buy
14,441
+877
+6% +$15K 0.11% 103
2014
Q3
$240K Buy
+13,564
New +$266K 0.11% 98

Other funds holding VIVO

Cardinal Capital Management Inc (North Carolina)'s VIVO Position: Q2 2019 in Review

Cardinal Capital Management Inc (North Carolina) sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 31,208 shares — an estimated $549K sold.

Cardinal Capital Management Inc (North Carolina) first reported a position in VIVO in Q3 2014 and held it in 19 quarters. The position peaked at $881K in Q2 2017. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

  • Cardinal Capital Management Inc (North Carolina) reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
  • Cardinal Capital Management Inc (North Carolina) sold 31,208 Meridian Bioscience Inc shares in Q2 2019, an estimated $549K.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 19 quarters.
  • Cardinal Capital Management Inc (North Carolina)'s Meridian Bioscience Inc position peaked at $881K in Q2 2017.
  • 173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2019, filed 8 Jul 2019.